Difference between revisions of "Campbell VT, et al. Mol. Cancer Ther. (2014) cited as Ref 227 in DOI: 10.1038/s41392-020-0110-5 (Q9490)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 13, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth (English) | ||
| Property / title: Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth (English) / rank | |||
| + | Normal rank | ||
Revision as of 21:55, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Campbell VT, et al. Mol. Cancer Ther. (2014) cited as Ref 227 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Campbell VT
0 references
2014
0 references
Mol. Cancer Ther.
0 references
13
0 references
Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth (English)
0 references
